| Non-Alcoholic Fatty Liver Disease |
1 |
1 |
| Biliary Disease |
0 |
0.9 |
| Cirrhosis |
0 |
0.81 |
| Metabolic Syndrome |
0 |
0.62 |
| Liver |
0 |
0.51 |
| Hepatocellular Carcinoma |
0 |
0.45 |
| Liver Biopsy |
0 |
0.42 |
| Liver Disease |
0 |
0.42 |
| Fatty Liver |
0 |
0.39 |
| End-Stage Liver Disease |
0 |
0.37 |
| Model for End-Stage Liver Disease |
0 |
0.34 |
| Biopsy |
0 |
0.17 |
| Body Mass Index |
0 |
0.13 |
| Clinical Research |
0 |
0.09 |
| Healthcare and Medical Technology |
0 |
0.08 |
| Alcohol Use |
0 |
0.04 |
| Cancer |
0 |
0.04 |
| Cyclooxygenase (COX) |
0 |
0.04 |
| Grant |
0 |
0.04 |
| Histology |
0 |
0.04 |
| Hospital |
0 |
0.04 |
| Indiana |
0 |
0.04 |
| Injury |
0 |
0.04 |
| Nonalcoholic Steatohepatitis |
0 |
0.04 |
| Nutrition |
0 |
0.04 |
| Wound Management |
0 |
0.04 |